Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	17,917	12,410	11,851	23,035	22,785	63,653
Market Cap Growth	4.61%	4.72%	-48.55%	1.10%	-64.20%	192.75%
Enterprise Value	16,428	11,035	10,382	21,271	20,540	62,660
Last Close Price	54.50	37.75	36.05	70.10	69.50	200.91
PE Ratio	-	-	-	-	-	45.14
PS Ratio	29.22	20.24	19.57	59.12	62.42	19.40
PB Ratio	5.15	3.57	3.08	5.99	4.53	13.61
P/TBV Ratio	5.18	3.59	3.10	6.05	4.57	13.77
P/FCF Ratio	-	-	1835.64	-	-	142.64
P/OCF Ratio	-	-	290.80	-	-	109.77
EV/Sales Ratio	26.79	18.00	17.14	54.59	56.27	19.10
EV/EBITDA Ratio	-	-	-	-	-	58.45
EV/EBIT Ratio	-	-	-	-	-	65.02
EV/FCF Ratio	-164.74	-	1608.05	-	-	140.41
Debt / Equity Ratio	0.08	0.08	0.09	0.51	0.39	0.04
Debt / EBITDA Ratio	-	-	-	-	-	0.17
Debt / FCF Ratio	-	-	52.50	-	-	0.42
Net Debt / Equity Ratio	-0.43	-0.43	-0.41	-0.46	-0.45	-0.44
Net Debt / EBITDA Ratio	12.01	12.01	60.26	1.62	1.60	-1.91
Net Debt / FCF Ratio	14.93	14.93	-244.21	3.42	1.69	-4.59
Asset Turnover	0.15	0.15	0.12	0.06	0.06	0.75
Inventory Turnover	0.59	0.59	0.50	0.25	0.76	2.84
Quick Ratio	10.35	10.35	9.54	1.99	12.48	6.54
Current Ratio	12.77	12.77	11.94	2.21	15.38	8.48
Return on Equity (ROE)	-7.69%	-7.69%	-2.09%	-26.14%	-30.39%	36.08%
Return on Assets (ROA)	-4.00%	-4.00%	-1.74%	-11.29%	-15.18%	13.71%
Return on Capital Employed (ROCE)	-7.10%	-7.10%	-3.50%	-29.60%	-22.00%	19.80%
Earnings Yield	-1.57%	-2.27%	-0.68%	-5.04%	-6.47%	2.22%
FCF Yield	-0.56%	-0.80%	0.05%	-2.26%	-5.94%	0.70%
Buyback Yield / Dilution	0.33%	0.33%	-0.10%	-1.50%	-0.73%	-15.82%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.